How CBD and Vijaya Products Are Manufactured: Seed-to-Shelf Controls

A bottle of CBD or Vijaya oil may look simple, but it is only the final chapter of a much longer story. Its quality depends on the plant, its handling, the laboratory findings and whether label claims trace to a real batch.

Think of manufacturing as a relay race. The supplier, production team, laboratory, packer and quality reviewer carry the same baton. If one drops it, a polished label cannot repair the gap. That is why “seed to shelf” should mean documented control, not just an attractive marketing phrase.

What does seed-to-shelf manufacturing mean?

Seed-to-shelf control means that a manufacturer can follow a product backwards—from the finished bottle to its packaging lot, test report, production batch and original botanical material. This traceability helps answer practical questions: Was the correct plant material used? Did it pass identity and contamination checks? Was the finished concentration measured? Can the company investigate a complaint or recall a batch if necessary?

1. The legal and quality blueprint comes first

In India, cannabis- and Vijaya-based medicines sit within a regulated landscape. The NDPS Act defines covered cannabis materials and “medicinal cannabis,” while manufacture, possession and sale are subject to applicable legal permissions. For Ayurvedic medicines, manufacturing licences are granted by the relevant State or Union Territory licensing authority—not by a website badge or a claim that a product is “AYUSH approved.”

A responsible business therefore establishes the permitted ingredient, product category, manufacturing licence, approved formula and label requirements before production begins. This article explains quality controls, not a recipe for home extraction. Concentrated cannabinoid products should not be manufactured outside lawful, properly controlled facilities.

2. Raw material: identity before promises

Plants naturally vary with genetics, soil, weather, harvest timing and storage. A supplier’s assurance is not enough. A qualified facility documents the source and lot, checks botanical identity, inspects appearance and foreign matter, and evaluates risks such as microbes, pesticides, heavy metals and mycotoxins where relevant.

Drying and storage matter too. Excess moisture can encourage microbial growth; heat, light and oxygen can change sensitive constituents. Clean containers, controlled storage and clear status labels—such as quarantined, approved or rejected—help prevent mix-ups. If the starting material is uncertain, precision later in the process becomes an illusion.

3. Extraction is not the whole story

Manufacturers may use different extraction approaches, including food-grade solvents or carbon dioxide systems, depending on the licensed process and intended product. The consumer does not need to be impressed by the name of a machine. What matters is whether the method is validated, consistently followed and able to control residues, concentration and unwanted contaminants.

After extraction, the material may be filtered, refined or standardised. A full-spectrum product aims to retain a wider range of plant compounds; a broad-spectrum product is processed to reduce or remove THC; an isolate centres on a purified single cannabinoid. These labels should be supported by formulation records and testing, not used loosely.

4. Formulation turns an extract into a measured product

An extract is not automatically a finished oil. It may be blended with a carrier oil and other approved ingredients to reach a defined concentration. The mixture must remain uniform, because the first portion and the last portion of a batch should not deliver completely different strengths. Calibrated equipment, controlled mixing, line clearance and in-process checks reduce errors.

Labels should state total cannabinoid content and a usable concentration—not hide behind phrases such as “high potency.”

5. GMP is the discipline behind consistency

Good Manufacturing Practices are the habits and systems that make repeatability possible: trained people, clean premises, written procedures, equipment maintenance, calibrated instruments, controlled documents and investigation of deviations. India’s Ayurvedic drug rules and quality standards emphasise raw-material control, in-process monitoring, finished-product testing, analytical records, retention samples and appropriate storage.

This matters because quality cannot depend on who happened to be working that day. If an unexpected result occurs, the team should record it, investigate the reason and decide whether the batch is safe to release—not simply retest until a convenient number appears.

6. What should the finished batch be tested for?

A credible batch report should match the batch number on the product. Depending on the formulation, relevant tests can include cannabinoid identity and potency, THC level, microbial limits, heavy metals, pesticides, residual solvents and other contaminants. The exact specification depends on the product type and applicable standards.

• Potency: Does the measured amount reasonably match the label?
• THC: Is the result consistent with the product claim and applicable legal controls?
• Contaminants: Were suitable limits and validated methods used?
• Laboratory identity: Is the report issued by a credible lab, with dates, methods and an authorised sign-off?

A generic report without a matching batch number is like receiving somebody else’s blood test—it may be real, but it does not answer your question.

7. Packaging, stability and the journey after filling

The right container protects the formulation from light, air, moisture and leakage. Packaging components should be suitable for the product, labels should remain legible, and tamper-evident features can help consumers notice interference. Stability data supports the shelf life and storage statement; an arbitrary expiry date does not.

Before release, quality reviewers should confirm that manufacturing, testing and packaging records are complete. Distribution and complaint records make investigation or recall possible later.

Red flags that deserve a pause

• No batch number, manufacturing licence details or responsible business address.
• A certificate that cannot be linked to the bottle in your hand.
• Claims to cure cancer, diabetes, epilepsy, anxiety or chronic pain without appropriate medical context.
• “Zero THC” or “100% pure” claims without credible batch testing.
• No ingredient list, concentration, warnings, expiry date or storage instructions.
• A seller discouraging you from discussing the product with your doctor.

Questions people often ask

Does CO₂ extraction automatically mean a better product?

No. It can be a useful controlled method, but equipment alone does not guarantee correct plant identity, clean inputs, accurate formulation or honest labelling. Judge the complete quality system.

Is every CBD or Vijaya product “AYUSH approved”?

That phrase can mislead. The Ministry of Ayush has clarified that it does not certify or approve individual companies and products. State or Union Territory licensing authorities grant manufacturing licences under the applicable rules.

Can a test report prove a product will work for me?

No. Testing can support identity, strength and contaminant control; it cannot predict your personal benefit or rule out interactions. Evidence for CBD varies greatly by condition, dose and product.

The sensible bottom line

Trust is not created by a green leaf on a label. It is earned through traceable materials, lawful production, disciplined manufacturing, batch-specific testing, careful packaging and honest communication about limits. Before buying, ask for documents that connect the plant, the process, the laboratory and the bottle. Then discuss the decision with a qualified clinician.

Sources and further reading

• India Code: NDPS Act definitions
• India Code: NDPS Act, Section 8
• Ministry of Ayush: 2025 quality-control and GMP notification
• Ministry of Ayush public notice on product approvals and licensing
• US FDA: CBD product quality and safety concerns

Written by: Dr Kartik Sharma for Sanan OrganiX